University of Oregon researchers have tested a new combination drug therapy that could dismantle the difficult-to-treat bacteria inhabiting chronic wound infections.

Looking “under the hood” of a cell during chlorate-antibiotic exposure will help investigate how bacteria become susceptible to a range of antibiotics.

Researchers have revealed how polymyxins, crucial last-resort antibiotics, break down bacterial armor by forcing cells to ...

The way antibiotics called polymyxins pierce the armour of bacteria has been revealed in stunning detail by high-resolution ...

A bacterial molecule enhances chemotherapy. Its synthetic form could inspire new cancer drugs. An international group of researchers, led by teams at the MRC (LMS), Imperial College London, and the ...

Antibiotic resistance has become one of the most pressing threats to global health. Infections once treatable with a simple ...

An injectable gel activated by low-dose X-rays delivers sustained antibacterial effects in deep tissue by generating reactive oxygen species, offering a non-antibiotic strategy for hard-to-treat ...

Artificial tissues that mimic the placenta, endometrium, ovary and vagina could point to treatments for common conditions ...

The bacterial molecules, believed to stay in the gut, are present in the brain and linked to sleep patterns, discovered Washington State University scientists. The findings challenge brain-centric ...

Short peptides can self-assemble into net-like structures that kill bacteria. Now, researchers have discovered how to control ...